These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38951593)
1. P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma. Chi Z; Wang Q; Wang X; Li D; Tong L; Shi Y; Yang F; Guo Q; Zheng J; Chen Z Sci Rep; 2024 Jul; 14(1):15023. PubMed ID: 38951593 [TBL] [Abstract][Full Text] [Related]
2. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway. Guo W; Qu Y; Yu Y; Li X; Liang Z; Wang Z; Hu T; Zhou S Aging (Albany NY); 2024 May; 16(10):9204-9215. PubMed ID: 38795388 [TBL] [Abstract][Full Text] [Related]
3. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC. Liu Y; Cao P; Xiao L; Tang N; Fei W; Li X J Cell Mol Med; 2024 Jul; 28(14):e18556. PubMed ID: 39039706 [TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway. Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280 [TBL] [Abstract][Full Text] [Related]
8. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma. Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505 [TBL] [Abstract][Full Text] [Related]
9. [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway]. Shang L; Jiang W; Zhang J; Wu W Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):665-672. PubMed ID: 35673909 [TBL] [Abstract][Full Text] [Related]
10. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway. Wu YL; Liu W; Zhao T; Jin J Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998 [TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway. Zhao Z; Chu W; Zheng Y; Wang C; Yang Y; Xu T; Yang X; Zhang W; Ding X; Li G; Zhang H; Zhou J; Ye J; Wu H; Song X; Wu Y Cell Commun Signal; 2021 Dec; 19(1):121. PubMed ID: 34922580 [TBL] [Abstract][Full Text] [Related]
12. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways. Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704 [TBL] [Abstract][Full Text] [Related]
13. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. Chang KP; Yu JS; Chien KY; Lee CW; Liang Y; Liao CT; Yen TC; Lee LY; Huang LL; Liu SC; Chang YS; Chi LM J Proteome Res; 2011 Nov; 10(11):4935-47. PubMed ID: 21859152 [TBL] [Abstract][Full Text] [Related]
14. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling. Li P; Xiao LY; Tan H Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway. Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway. Wang Q; Lv L; Li Y; Ji H Mol Med Rep; 2018 Sep; 18(3):3106-3114. PubMed ID: 30015840 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
18. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway. Tang G; Tang Q; Jia L; Chen Y; Lin L; Kuai X; Gong A; Feng Z Int J Mol Med; 2019 Dec; 44(6):2161-2170. PubMed ID: 31638186 [TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma. Zhu L; Shen Y; Sun W Biomed Pharmacother; 2017 Jan; 85():712-717. PubMed ID: 27923688 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway. Wang Q; Zhang X; Song X; Zhang L Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]